Camp4 Therapeutics (CAMP) Enterprise Value (2024 - 2026)

Camp4 Therapeutics has reported Enterprise Value for 4 years, with the latest figure at -$99.9 million in Q1 2026.

• Quarterly Enterprise Value fell 102.72% year-over-year to -$99.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$99.9 million (down 102.72% YoY) and the FY2025 annual result came in at -$110.9 million, down 73.12% from the prior year.
• Enterprise Value grew to -$99.9 million in Q1 2026 per CAMP's latest filing, from -$110.9 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$2.5 million in Q3 2024 and troughed at -$110.9 million in Q4 2025.
• A 4-year average of -$58.9 million and a median of -$50.5 million in 2023 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value surged 94.99% in 2024, then tumbled 2876.86% in 2025.
• Over 4 years, Enterprise Value stood at -$38.4 million in 2023, then slumped by 66.86% to -$64.0 million in 2024, then slumped by 73.12% to -$110.9 million in 2025, then climbed by 9.85% to -$99.9 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$99.9 million, -$110.9 million, and -$75.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.